Results 401-420 of 1,065,643 for in 'Dáil debates' OR in 'Committee meetings' (speaker:John Dolan OR speaker:Denis Naughten OR speaker:Barry Cowen OR speaker:Malcolm Noonan OR speaker:Paul McAuliffe OR speaker:Richard Bruton OR speaker:Darragh O'Brien OR speaker:Martin Browne OR speaker:Jennifer Whitmore OR speaker:Damien English OR speaker:Brendan Griffin OR speaker:Seán Haughey OR speaker:Thomas Gould OR speaker:Róisín Shortall OR speaker:Pauline Tully OR speaker:Matt Shanahan)

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Paul McAuliffe: Is that about trying to find places for treatment?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Paul McAuliffe: And Mr. Duffin?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: I appreciate the witnesses' being here. My first questions are for Ana Liffey. Previously those working in the addiction sector have raised concerns about bureaucracy, red tape and engagement on research through the HRB. They say it is an added layer of work that sometimes acts as a barrier to supporting their clients. Has Mr. Duffin found that?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: However, Ana Liffey needs resources to do that type of work. My point is that we do not want workers who do work specifically for clients being diverted to doing administration or research, which are also very important. In order to make decisions, we need accurate data.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: However, Ana Liffey should not be pulling resources from services to do that.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: My colleague and friend Deputy Maurice Quinlivan from Limerick told me about the Ana Liffey's brilliant LEAR project. I ask Mr. Duffin to outline-----

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: That is good to hear. Regarding the drug courts, how long do interactions with a person last in the drug treatment court on average? Is the programme still a pilot? Are there plans to expand it to other cities?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: My question was on the average length of time in the system. Ms Foley said it is about 24 months.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: My next question is for all the guests. Are there supports to prevent staff turnover and burnout in their services? Have they experience of these problems? What could we do to keep staff? When we lose staff, we lose expertise, including that of people on the front line doing very critical work. Have the guests a comment to make on that?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: I do not mean my last question to be political but it has to be. The budget was announced last week and we are here today to consider the recommendations of the citizens’ assembly. Do the witnesses feel the budget will provide the funding needed to deliver what was recommended by the assembly?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: It is probably unfair to ask the question. There was not a single word about addiction in the budget. There are citizens’ assembly recommendations and we are now trying to introduce a policy, having listened to those present and many other groups, but I do not believe there is the will in certain parts of the Government and the Department, to be realistic. We have been talking about...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: I have to go back to the Chamber. In case the witnesses are not here when I come back, I thank them for their attendance. I apologise that I have had to be in and out of meetings and the Chamber.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: I am sorry Chair, I would like to apologise. As I said earlier, I had to pop out as I was speaking in the Chamber. I would like to make a comment.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (10 Oct 2024)

Thomas Gould: I just want to put on the record that I would like to make a statement. The Chair has said that comments will be taken in private session. I accept that as the Deputy is the Chair of the meeting. However, as the party spokesman on addiction, recovery and well-being and as a member of the committee, I wanted to comment.

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Export Controls (10 Oct 2024)

Matt Carthy: Over the past year, as the genocide in Gaza in particular has intensified and as a global boycott campaign has grown, the Israeli economy contracted quite an amount. Its credit rating has been downgraded multiple times and its economy has suffered across virtually every sector. Yet, one area that is apparently booming is its trade in dual-use items with a military purpose with Ireland in...

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Export Controls (10 Oct 2024)

Catherine Connolly: Go raibh maith agat.

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Export Controls (10 Oct 2024)

Matt Carthy: Will the Minister explain precisely what human rights provisions are taken into account? To my knowledge, no such export licence has ever been denied.

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Export Controls (10 Oct 2024)

Micheál Martin: The Department of Foreign provided observations in 31 export licence requests where the end use country was Israel in 2024. The Department of Foreign Affairs previously provided 116 cases of foreign policy observations generally across the board to the Department of Enterprise, Trade and Employment on dual-use export licence applications to Israel since 2020, over the past four years. In...

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Export Controls (10 Oct 2024)

Matt Carthy: I am told there is a quote in respect of a number of licences and the fact that they have grown that they raise a higher or potentially more serious risk of misuse because they are going to state agencies or linked companies. That is in respect of dual-use items exported to Israel. To be clear, when a state, whether it be Russia, Israel or any other oppressive state, is currently engaged in...

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Export Controls (10 Oct 2024)

Catherine Connolly: Go raibh maith agat.